Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 48, Issue 4, 2008, Pages 447-

  Nicklin, Jim ^a   Perrin, Lewis ^a   Crandon, Alex ^a   Land, Russell ^a   Nascimento, Marcelo ^a   Obermair, Andreas ^a  

^a Queensland Centre for Gynaecological Cancer   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLEEDING; BLOOD CLOTTING DISORDER; ERYTHROCYTE CONCENTRATE; HUMAN; HYSTERECTOMY; LETTER; MORBIDITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION;

ALGORITHMS; AUSTRALIA; COAGULANTS; FACTOR VIIA; FEMALE; HUMANS; HYSTERECTOMY; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; RECOMBINANT PROTEINS;

EID: 50849095751     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2008.00897.x     Document Type: Letter

References (1)

1. Welsh A, McLintock C, Gatt S, Somerset D, Popham P, Ogle R. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2008 48 : 12 16.